Frontiers in Nanopharmacy and Clinical Therapeutics

Frontiers in Nanopharmacy and Clinical Therapeutics* presents recent advances in pharmaceutical sciences, integrating nanotechnology, molecular biology, artificial intelligence, precision medicine, and innovative therapeutic strategies. The book highlights multidisciplinary approaches in modern drug discovery, emphasizing the role of computational biology, genomics, medicinal chemistry, and pharmacology in developing safer and more effective therapeutics. It explores major healthcare challenges including viral infections, hypertension, cancer, metabolic disorders, and rare genetic diseases, while discussing emerging treatment modalities such as targeted therapy, stem cell therapy, RNA interference, CRISPR-based genome editing, and personalized medicine. Special focus is given to precision oncology, pharmacovigilance systems, herbal medicine safety, and novel oral antidiabetic agents, reflecting the growing importance of patient-centered and technology-driven healthcare. The text also examines advanced tools such as swarm robotics, artificial intelligence, and high-throughput screening for improving drug safety monitoring and therapeutic outcomes. In addition, the book addresses vaccine development, regenerative medicine, and biomarker-based diagnostics that contribute to translational and clinical research. Designed for researchers, academicians, clinicians, and students, this volume provides a comprehensive overview of current innovations and future perspectives in nanopharmacy and clinical therapeutics, promoting interdisciplinary collaboration for the advancement of modern healthcare and pharmaceutical research.